A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease

BACKGROUND: Chronic kidney disease (CKD) is associated with an increased risk of hepatitis B infection and impaired seroconversion to hepatitis B vaccine (HBV). Studies examining augmented vaccine schedules to enhance seroconversion have so far been inconclusive. Furthermore, the defects responsible...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Elizabeth N., Baker, Alan, Alshekaili, Jalila, Karpe, Krishna, Cook, Matthew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179249/
https://www.ncbi.nlm.nih.gov/pubmed/30303980
http://dx.doi.org/10.1371/journal.pone.0204477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179249/
https://www.ncbi.nlm.nih.gov/pubmed/30303980
http://dx.doi.org/10.1371/journal.pone.0204477

Ejemplares similares